Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Are Methods for Evaluating Medications Appropriate for Evaluating Nonpharmacological Treatments for Pain?—Challenges for an Emerging Field of Research

Are Methods for Evaluating Medications Appropriate for Evaluating Nonpharmacological Treatments... Research Original Investigation Effectiveness of Mindfulness Meditation vs Headache Education for Adults With Migraine migraine: an effectiveness trial with a one-year clinical trial. JAMA. 2018;319(19):1999-2008. without aura: preliminary data of a phase-II, follow-up. J Headache Pain. 2017;18(1):15. doi:10. doi:10.1001/jama.2018.4853 multicentric, randomized, open-label study. Neurol 1186/s10194-017-0728-z Sci. 2019;40(suppl 1):191-192. 75. Lipton RB, Desai P, Sapra S, Buse DC, Fanning 72. Seminowicz DA, Burrowes SAB, Kearson A, et al KM, Reed ML. How much change in 78. Kuruvilla D, Wells RE. Evidence-based Enhanced mindfulness-based stress reduction in headache-related disability is clinically meaningful? integrative treatments for headache. Headache. episodic migraine: a randomized clinical trial with estimating minimally important difference (MID) or 2019;59(6):971-972. doi:10.1111/head.13555 magnetic resonance imaging outcomes. Pain. change in MIDAS using data from the AMPP study. 79. Wells RE, Strauss LD. The value of Published online March 13, 2020. doi:10.1097/ Headache. 2017;57(53):165-166. headache-specific recommendations during j.pain.0000000000001860 76. Pressman A, Law H, Stahl R, et al. Conducting a COVID-19. Headache. 2020;60(5):820-823. 73. Silberstein SD, Stauffer VL, Day KA, Lipsius S, pilot randomized controlled trial of doi:10.1111/head.13821 Wilson MC. Galcanezumab in episodic migraine: community-based mindfulness-based stress 80. Chowdhury D, Datta D. Managing migraine in subgroup analyses of efficacy by high versus low reduction http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Are Methods for Evaluating Medications Appropriate for Evaluating Nonpharmacological Treatments for Pain?—Challenges for an Emerging Field of Research

JAMA Internal Medicine , Volume 181 (3) – Mar 14, 2021

Loading next page...
 
/lp/american-medical-association/are-methods-for-evaluating-medications-appropriate-for-evaluating-5psp4Ru5bK
Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2020.7081
Publisher site
See Article on Publisher Site

Abstract

Research Original Investigation Effectiveness of Mindfulness Meditation vs Headache Education for Adults With Migraine migraine: an effectiveness trial with a one-year clinical trial. JAMA. 2018;319(19):1999-2008. without aura: preliminary data of a phase-II, follow-up. J Headache Pain. 2017;18(1):15. doi:10. doi:10.1001/jama.2018.4853 multicentric, randomized, open-label study. Neurol 1186/s10194-017-0728-z Sci. 2019;40(suppl 1):191-192. 75. Lipton RB, Desai P, Sapra S, Buse DC, Fanning 72. Seminowicz DA, Burrowes SAB, Kearson A, et al KM, Reed ML. How much change in 78. Kuruvilla D, Wells RE. Evidence-based Enhanced mindfulness-based stress reduction in headache-related disability is clinically meaningful? integrative treatments for headache. Headache. episodic migraine: a randomized clinical trial with estimating minimally important difference (MID) or 2019;59(6):971-972. doi:10.1111/head.13555 magnetic resonance imaging outcomes. Pain. change in MIDAS using data from the AMPP study. 79. Wells RE, Strauss LD. The value of Published online March 13, 2020. doi:10.1097/ Headache. 2017;57(53):165-166. headache-specific recommendations during j.pain.0000000000001860 76. Pressman A, Law H, Stahl R, et al. Conducting a COVID-19. Headache. 2020;60(5):820-823. 73. Silberstein SD, Stauffer VL, Day KA, Lipsius S, pilot randomized controlled trial of doi:10.1111/head.13821 Wilson MC. Galcanezumab in episodic migraine: community-based mindfulness-based stress 80. Chowdhury D, Datta D. Managing migraine in subgroup analyses of efficacy by high versus low reduction

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Mar 14, 2021

References